Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - May 2017

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2017. This month there are two guidelines that impact upon primary care.

The Type 2 diabetes in adults guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels and identifying and managing long-term complications. It has been updated to include sodium–glucose cotransporter 2 (SGLT-2) inhibitors in the section on drug treatment and the algorithm for blood glucose lowering therapy has been also updated to include these treatment options.

The Eating disorders: recognition and treatment guideline covers the assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa. The guideline includes recommendations on identifying eating disorders.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - May 2017' on Email Share 'NICE Guidance - May 2017' on Delicious Share 'NICE Guidance - May 2017' on Digg Share 'NICE Guidance - May 2017' on Facebook Share 'NICE Guidance - May 2017' on Google+ Share 'NICE Guidance - May 2017' on reddit Share 'NICE Guidance - May 2017' on StumbleUpon Share 'NICE Guidance - May 2017' on Twitter

atomic-wealth

No Comments to “NICE Guidance - May 2017”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,316 spam comments.

atomic-wealth
fond-illness
summer